购物车
全部删除
您的购物车当前为空
Androgen receptor antagonist 4 (Compound AT2) 表现出抗癌活性。Androgen receptor antagonist 4 有效拮抗 AR 的转录活性,抑制 AR 的下游靶基因,并阻断 DHT 诱导的 AR 核转位。它是雄激素受体 (AR) 的拮抗剂 (IC50 = 0.15 μM)。

Androgen receptor antagonist 4 (Compound AT2) 表现出抗癌活性。Androgen receptor antagonist 4 有效拮抗 AR 的转录活性,抑制 AR 的下游靶基因,并阻断 DHT 诱导的 AR 核转位。它是雄激素受体 (AR) 的拮抗剂 (IC50 = 0.15 μM)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 14,900 | 6-8周 | |
| 50 mg | ¥ 19,420 | 6-8周 | |
| 100 mg | ¥ 24,625 | 6-8周 |
Androgen receptor antagonist 4 相关产品
| 产品描述 | Androgen receptor antagonist 4 (Compound AT2) has anticancer activities. Androgen receptor antagonist 4 potently antagonizes the activity of AR transcriptional, inhibits downstream target gene of AR, and blocks the DHT-induced nuclear translocation of AR. Androgen receptor antagonist 4 is an antagonist of androgen receptor (AR) (IC 50 = 0.15 μM) [1]. |
| 分子量 | 331.84 |
| 分子式 | C22H18ClN |
| CAS No. | 354815-43-3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容